Effect of Myricetin in Protection of Cells From Photodamage ID'd

This article originally appeared here.
Share this content:
Effect of Myricetin in Protection of Cells From Photodamage ID'd
Effect of Myricetin in Protection of Cells From Photodamage ID'd

THURSDAY, Aug. 24, 2017 (HealthDay News) -- Myricetin protects cells from photodamage via the IκB/NFκB signaling pathway, according to a study published online Aug. 17 in the Journal of Cosmetic Dermatology.

Jing Xie, M.D., from Shangdong University in Jinan, and Yanyan Zheng, M.D., from the Wenzhou People's Hospital -- both in China, examined the effect of myricetin on human keratinocyte cell line (HaCaT) cells. The authors performed a cell viability assay and measured reactive oxygen species (ROS).

The researchers found that, as determined by the cell viability assay, ultraviolet (UV)-induced keratinocyte death was attenuated by myricetin in a dose-dependent manner. Myricetin pretreatment also reduced the UV-induced ROS levels. Real-time polymerase chain reaction and Western blot showed that myricetin suppressed the upregulation of COX2 induced by UV in keratinocyte. In signal transduction studies, myricetin was confirmed to attenuate COX2 upregulation induced by UV via suppression of IκB/NFκB pathways.

"These results showed that antioxidant property of myricetin can effectively attenuate UV-caused cell damage and suppress the expression of COX2 through the IκB/NFκB signaling pathways," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »